Allergan shares fall

PHARMACEUTICAL group Allergan saw shares fall by 4pc after sales of Botox fell short of analysts' estimates.

The US-based company, which employs 800 people in Westport, reported that first-quarter sales of Botox rose to $398.9m (¤302m).

Allergan has been trying to expand the use of Botox for treating migraines.